Q6FNX7 AF NFT

Topoisomerase 1-associated factor 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieh7fqfigpx73blxjfkx2sw4htupnfaxdy7dcze3p2obsp3znvdzq/metadata.json
IPFS of structure file: 
bafybeigikrqng7n6bgy5kuylmqmhf2edyf4e5ouxwaqueqdtgpn6byt4w4/AF-Q6FNX7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd10960F956646DE8b64d3598984c91C2d5Af3D7b
First NFT owner address (bech32): 
genesis16yykp72kv3k73djdxkvfsny3ct2670tm7h5hjv
Current NFT ID #469425 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
469425
Accession (UniProt):
Q6FNX7
Name::
Topoisomerase 1-associated factor 1
Experimental Method:
Predicted structure
Sequence source:
CANDIDA GLABRATA (STRAIN ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6FNX7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6FNX7|TOF1_CANGA Topoisomerase 1-associated factor 1 OS=Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) OX=284593 GN=TOF1 PE=3 SV=1 MSDTESPLTVLKARIALLATAIGGPDYTSQIDPPPYQIGDDCLACLKDLKRWFRLVDDNQRRWDVAMAVAEYKILTDDLLPILIDWENKCYLATKLSKGNSDISAHFKNKQYYDKIALNCLQLMVLMTWPLILTEQSSTNQINLYSELKKHQLTYKKAILSVENGKVLKAAIRIAIDVIKLDRLARTPRDNMVLKMVLNFIRNILAIEPGELTITARKNIASKGINSVDTLPPNVTQDDISQSTVISCFKKNKVFPFLLTLGSSMTKEFDQDFINIPLMEVMFFLTKDISQDSLLFKSGELDTAQSENHLSKAGQELNDLLQKESQLKKKVIMNTSTRHSRFGAMLSIQTLDQKRLTVSGSQNLLDNSKALQKIDDSKKSKGRRPMIRNETDNESLPTNLLNVHKKSGTYLPLTISKYLNDFINDFIDSSFNYLLKSVTNYFVTEEDKIISLEKIEYLLFFAWFNKYQILRCQVDKDADIMMISESIKETTFILVSSLLRSSYDSKAWAVVHSSMLAFNELLKLVNSLKKFEDNEDIEYVLSRLFSDERIQLLSNLPRIASTHSLSFMKTSIELTHTVLKILEMYSGDNSLVVESKRRAKKMKSISKEDYERLVNEEGYDPDEAIEILNPGHKTIVINFKRVQSSFFHRNTIDLYINTLKRFNELEYSHIKMIISFLYRLFVENNEETLFYRLDFIILLKDMLKQDGLPRTSKARTHINDFAKYYLSRLKRKLKSSPAWHVGILFPPLNDGVVGYFQKYGEHKMTKESEIYAVQPSQFIPFEQQEMMSENMILDMQIGVLVSTLIDEGSQNLVELVRENVQHLIAVFTSHLEVAGENEKTPNNEAFILKEEYDVNPLHYNRHIRALLQLVGFEIPILKSDPCFYRGTTEFSRLVKCEESITKYLNIPFETPNGLPSSSYLKQQSEKNNSLESDGWKGNEDYDYTDPNIVPDNEVDDNDYFKDLDKSTNIRKEKRTVGIASKKTQSKNKTSRNRKKASFRLPNAIEGKDKQPQENLEVFSKEYISDSDEDDEEILNPVFFENEMYMRWLLDKYNGQLPNDKFLSFGRFVNERLSNNGKVVSDFTSLFDGPVPPIDALPLEGITRKGPDKTLLTLSRVEINESNQDNENTQVNEQVDETSENLTINKNARNIGISHGHVESEADDDEPITKKRRTSAN